Gamida Cell is gearing up to begin sales of omidubicel from Israel to US hospitals for use in stem cell transplants, pending FDA approval of the therapy.
Paroxysmal nocturnal hemoglobinuria (PNH) is a condition that is poorly defined and difficult to diagnose. Characterized by episodic complement-mediated hemolysis, its classic presentation is the sudden, episodic, and night-time occurrence of hemoglobin in the urine. The most common symptom shared by patients with this disease is debilitating fatigue. According to the International Paroxysmal Nocturnal Hemoglobinuria…
Which of the statements below about the therapies for paroxysmal nocturnal hemoglobinuria (PNH) are correct? Select one of the options for each question, then submit your answers to see your score and the average score for everyone who has taken the quiz. Read more about PNH therapies.
PNH has been described as the “great impersonator” due to its ability to present with nonspecific symptoms.
